Eileen Wu

Comparative Risk for Angioedema Associated With the Use of Drugs That Target the Renin-Angiotensin-Aldosterone System

Sengwee Toh, Marsha E. Reichman, Monika Houstoun et al. · Archives of Internal Medicine · 2012 · 212 citations

Adverse event detection using the FDA post-marketing drug safety surveillance system: Cardiotoxicity associated with loperamide abuse and misuse

Kimberley Swank, Eileen Wu, Cindy Kortepeter et al. · Journal of the American Pharmacists Association · 2017 · 53 citations

Drug Safety, Cardiovascular Disease, Adverse Event +10

Sources of Evidence Triggering and Supporting Safety-Related Labeling Changes: A 10-Year Longitudinal Assessment of 22 New Molecular Entities Approved in 2008 by the US Food and Drug Administration

David Croteau, Ellen Pinnow, Eileen Wu et al. · Drug Safety · 2022 · 26 citations

Drug Safety, Preventive Medicine, Evidence Triggering +11

Postmarketing cases of eluxadoline‐associated pancreatitis in patients with or without a gallbladder

Lisa Harinstein, Eileen Wu, Allen Brinker · Alimentary Pharmacology & Therapeutics · 2018 · 24 citations · Full text

Asian American Youth, the Dance Scene, and Club Drugs

Geoffrey Hunt, Kristin Evans, Eileen Wu et al. · Journal of Drug Issues · 2005 · 23 citations

Ethnicity, Education, Club Drug Use +19